NM_015175.3:c.6880G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_015175.3(NBEAL2):c.6880G>A(p.Glu2294Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,613,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015175.3 missense
Scores
Clinical Significance
Conservation
Publications
- gray platelet syndromeInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152194Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000562 AC: 14AN: 249062 AF XY: 0.0000518 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461452Hom.: 0 Cov.: 34 AF XY: 0.0000179 AC XY: 13AN XY: 727012 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000145 AC: 22AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.6880G>A (p.E2294K) alteration is located in exon 43 (coding exon 43) of the NBEAL2 gene. This alteration results from a G to A substitution at nucleotide position 6880, causing the glutamic acid (E) at amino acid position 2294 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at